Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Net Margin: 2021-2024

Historic Net Margin for Kiniksa Pharmaceuticals International (KNSA) over the last 4 years, with Dec 2024 value amounting to -10.21%.

  • Kiniksa Pharmaceuticals International's Net Margin rose 2150.00% to 10.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.01%, marking a year-over-year increase of 2776.00%. This contributed to the annual value of -10.21% for FY2024, which is 1214.00% up from last year.
  • Kiniksa Pharmaceuticals International's Net Margin amounted to -10.21% in FY2024, which was up 54.33% from -22.35% recorded in FY2023.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Net Margin ranged from a high of 2,674.30% in FY2022 and a low of -429.82% during FY2021.
  • Its 3-year average for Net Margin is 880.58%, with a median of -10.21% in 2024.
  • Per our database at Business Quant, Kiniksa Pharmaceuticals International's Net Margin surged by 310,412bps in 2022 and then crashed by 269,665bps in 2023.
  • Over the past 4 years, Kiniksa Pharmaceuticals International's Net Margin (Yearly) stood at -429.82% in 2021, then spiked by 310,412bps to 2,674.30% in 2022, then tumbled by 269,665bps to -22.35% in 2023, then soared by 1,214bps to -10.21% in 2024.